Market Research Reports Atrial Fibrillation Patient Digital Landscape | Page 2

Access Devices, Cardiac Monitors, Intracardiac Echocardiography (ICE) Systems, Left Atrial
Appendage (LAA) and Closure Devices and others.
As per the geographic analysis, North America holds a dominant position in the market, accounting
for the largest market share. APAC region is expected to be the fastest growing region with a healthy
CAGR during the forecast period (2019 - 2023). Japan accounted for the highest share of the total
APAC market in 2015; while China is poised to grow at highest CAGR during the analysis period. This
growth in this region is attributed to the rise in the prevalence of cardiac arrhythmia in developing
countries (such as India and China) owing to the large geriatric population.
Top Leading Key Players in Global Atrial Fibrillation (AF) Market: Cardiofocus, Biosense Webster,
Biotitic Se & Co. Kg, St. Jude Medical, Medtronic, Carima, Boston Scientific Corporation, Ncontact,
Agricore and others. New product launches and continuous technological innovations are the key
strategies adopted by the major players.
Latest Industry News:
St. Jude Medical (May 21, 2019) – Triluminate Study Shows Treatment with Abbott's First-of-its-kind
Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks – Abbott (NYSE: ABT) today
announced positive late-breaking data from its TRILUMINATE study of the company's minimally
invasive tricuspid valve repair system. Results at 30 days demonstrated that the investigational
device is associated with a reduction of tricuspid regurgitation (TR) symptoms – caused by a leaky
tricuspid heart valve – suggesting a possible treatment option for people suffering from this difficult-
to-manage structural heart disease. Abbott's transcatheter tricuspid valve repair (TTVR) system
builds on the continued advances of the company's proven clip-based MitraClip technology, which
treats people with leaky mitral valves.
Results from the TRILUMINATE study were presented in a late-breaking trial session at EuroPCR, the
annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
"Treating a leaky tricuspid heart valve has long presented a significant challenge for cardiologists
because it is an extremely complex and difficult heart valve to treat," said Georg Nickenig, M.D.,
Ph.D., professor and chief, Department of Cardiology, University Hospital, Bonn, Germany, and lead
investigator of the study. "These data are extremely encouraging, and I am excited about the
potential of transcatheter tricuspid valve repair as a minimally invasive treatment option for these
very ill patients who have no other options."
Region segment: This report is segmented into several key regions, with sales, revenue, market
share (%) and growth Rate (%) of Atrial Fibrillation in these regions, from 2013 to 2023 (forecast),
covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents
on “Global Atrial Fibrillation Market Report 2019” @
https://www.businessindustryreports.com/buy-now/162993/single .
About us